Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Mills

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Pathobiology Reports|January 23, 2018
The Regulation of Notch Signaling in Retinal Development and RegenerationElizabeth A Mills, Daniel Goldman
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2018
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patientsElizabeth A Mills, Yang Mao-Draayer
Frontiers in Immunology|February 20, 2018
Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye ViewElizabeth A Mills, Yang Mao-Draayer
Nature Chemical Biology|November 1, 2025
Intrinsically disordered domains expand the CAR T cell toolboxTristan Yoder, Elizabeth A Mills, Wan-Lin Lo
Nature Chemical Biology|November 14, 2025
Publisher Correction: Intrinsically disordered domains expand the CAR T cell toolboxTristan Yoder, Elizabeth A Mills, Wan-Lin Lo
Frontiers in Neurology|April 21, 2017
Emerging Approaches for Validating and Managing Multiple Sclerosis RelapseElizabeth A Mills, Ali Mirza, Yang Mao-Draayer
Auto- Immunity Highlights|November 17, 2017
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatmentFanny Huynh Du, Elizabeth A Mills, Yang Mao-Draayer
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MSElizabeth A Mills, Joel A Begay, Caitlyn Fisher, et al.
The Journal of Physical Chemistry. B|October 25, 2012
Large assembly formation via a two-step process in a chromonic liquid crystalElizabeth A Mills, Margaret H Regan, Vesna Stanic, et al.
Frontiers in Neurology|February 8, 2018
Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple SclerosisElizabeth A Mills, Magdalena A Ogrodnik, Andrew Plave, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Pathobiology Reports|January 23, 2018
The Regulation of Notch Signaling in Retinal Development and RegenerationElizabeth A Mills, Daniel Goldman
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2018
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patientsElizabeth A Mills, Yang Mao-Draayer
Frontiers in Immunology|February 20, 2018
Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye ViewElizabeth A Mills, Yang Mao-Draayer
Nature Chemical Biology|November 1, 2025
Intrinsically disordered domains expand the CAR T cell toolboxTristan Yoder, Elizabeth A Mills, Wan-Lin Lo
Nature Chemical Biology|November 14, 2025
Publisher Correction: Intrinsically disordered domains expand the CAR T cell toolboxTristan Yoder, Elizabeth A Mills, Wan-Lin Lo
Frontiers in Neurology|April 21, 2017
Emerging Approaches for Validating and Managing Multiple Sclerosis RelapseElizabeth A Mills, Ali Mirza, Yang Mao-Draayer
Auto- Immunity Highlights|November 17, 2017
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatmentFanny Huynh Du, Elizabeth A Mills, Yang Mao-Draayer
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MSElizabeth A Mills, Joel A Begay, Caitlyn Fisher, et al.
The Journal of Physical Chemistry. B|October 25, 2012
Large assembly formation via a two-step process in a chromonic liquid crystalElizabeth A Mills, Margaret H Regan, Vesna Stanic, et al.
Frontiers in Neurology|February 8, 2018
Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple SclerosisElizabeth A Mills, Magdalena A Ogrodnik, Andrew Plave, et al.
Pageof 4